CuraDose provides Y-90 SIRT treatment planning as a service - enabling hospitals to offer radioembolization with expert-level dosimetry, without building in-house capacity.
Hospitals submit cases through our secure physician portal. Our expert team handles the rest - from DICOM analysis to personalized treatment plans.
Step 1
Choose the service you need: eligibility assessment, treatment planning, or post-treatment verification.
Step 2
Upload DICOM imaging and clinical data through the secure CuraDose portal. Patient data is automatically pseudonymized at the point of upload.
Step 3
Our dosimetrists and clinical experts create a personalized treatment plan using FDA-cleared, CE-approved software, with quality assurance at every step.
Step 4
The completed plan and full dosimetry report arrive in the portal, ready for physician review and clinical use.
CuraDose combines decades of experience in interventional oncology, nuclear medicine, radiotherapy and medical physics.
Commercial & Clinical Strategy
Former Global Medical Director at a leading medical device company, with extensive experience in interventional oncology market development.
Clinical & Academic Leadership
Professor of Nuclear Medicine at UMC Utrecht, bringing world-class clinical expertise in radioembolization and nuclear medicine.
Platform & Product
Background in radiotherapy (Erasmus MC, Elekta) and medical devices (Global R&D Director). Architect of the CuraDose platform.
Radioembolization planning involves imaging and clinical data for identifiable patients. Privacy and compliance are built into how the platform works, from upload through to plan delivery.
Patient data is pseudonymized automatically as it enters the portal. Directly identifying information is removed at the point of upload, before it reaches our dosimetrists.
We process only the data needed to produce a treatment plan, use it for that purpose alone, and support the data-processing agreements your institution requires.
All data is stored and processed on infrastructure hosted within the European Union. Patient data does not leave the EU.
Data is encrypted in transit and at rest. Access to patient studies is limited to authorised members of the CuraDose clinical team on a need-to-know basis.
Hospital information-security teams need documentation to approve a new service. We provide the technical and organisational detail your IT and data-protection officers require. Start the conversation early and we will support your internal review.
Whether you are a hospital looking to start a radioembolization program or a vendor exploring partnership opportunities - tell us what you need and we will get back to you.
Your message has been sent. We will get back to you shortly.